Characteristics of Peripheral Immune Response Induced by Large-vessel Occlusion in Patients with Acute Ischemic Stroke

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Dec 25

PMID 39719974

Authors

Ling Ma

Bin Sun

Chenliu Fan

Juan Xiao

Maomao Geng

Jie Liu

Runze Jiang

Yang Jiang

Dianwei Liu

Affiliations

Soon will be listed here.

Abstract

Introduction: Despite improvements in the treatment of acute ischemic stroke (AIS), some patients still suffer from functional impairments, indicating the poor understanding of pathophysiologic process of AIS. Inflammation plays an important role in the pathophysiology of AIS. The purpose of the study was to investigate the peripheral inflammation in different subtypes of AIS.

Methods: Here, retrospective data from AIS with large vessel occlusion (LVO) and small vessel occlusion (SVO), and healthy controls, were initially analyzed. Then, flow cytometry was performed to evaluate the levels of peripheral naïve and memory T-cells. Finally, we characterized the T cell receptors (TCR) repertoire using high-throughput sequencing.

Results: Elevated levels of leukocytes, neutrophils, and neutrophil-to-lymphocyte ratio (NLR), and decreased levels of lymphocytes were found in LVO group than that in SVO group, which were correlated with the severity of LVO. In addition, higher percentages of both effector memory (Tem) and central memory (Tcm) T cells, and lower percentage of naïve T cells in CD4 and CD8 T cells, were found in LVO group than that in SVO and healthy groups. Moreover, impaired TCR diversity, and different abundances of V-J gene combinations and amino acid sequences, were found in LVO as compared with healthy group, which would be potential biomarkers for LVO diagnosis.

Discussion: In conclusion, AIS with LVO can rapidly induce peripheral immune response, which provides new insight into the understanding of pathophysiology of AIS.

References

Jayaraj R, Azimullah S, Beiram R, Jalal F, Rosenberg G . Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019; 16(1):142. PMC: 6617684. DOI: 10.1186/s12974-019-1516-2. View

Rosati E, Dowds C, Liaskou E, Henriksen E, Karlsen T, Franke A . Overview of methodologies for T-cell receptor repertoire analysis. BMC Biotechnol. 2017; 17(1):61. PMC: 5504616. DOI: 10.1186/s12896-017-0379-9. View

Lehmann M, Kallaur A, Oliveira S, Alfieri D, Delongui F, de Sousa Parreira J . Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes. Metab Brain Dis. 2015; 30(6):1417-28. DOI: 10.1007/s11011-015-9731-8. View

Wang Y, Cui W, Wu H, Xu X, Xu X . The role of T cells in acute ischemic stroke. Brain Res Bull. 2023; 196:20-33. DOI: 10.1016/j.brainresbull.2023.03.005. View

Ye X, Wang Z, Ye Q, Zhang J, Huang P, Song J . High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis. Front Immunol. 2020; 11:1618. PMC: 7423971. DOI: 10.3389/fimmu.2020.01618. View

Adams Jr H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41. DOI: 10.1161/01.str.24.1.35. View

Li Q, Tian Y, Niu J, Guo E, Lu Y, Dang C . Identification of diagnostic signatures for ischemic stroke by machine learning algorithm. J Stroke Cerebrovasc Dis. 2024; 33(3):107564. DOI: 10.1016/j.jstrokecerebrovasdis.2024.107564. View

Hang J, Huang J, Zhou S, Wu L, Zhu Y, Zhu L . The clinical implication of CD45RA naïve T cells and CD45RO memory T cells in advanced pancreatic cancer: a proxy for tumor biology and outcome prediction. Cancer Med. 2019; 8(3):1326-1335. PMC: 6434335. DOI: 10.1002/cam4.1988. View

Liesz A, Zhou W, Na S, Hammerling G, Garbi N, Karcher S . Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci. 2013; 33(44):17350-62. PMC: 6618366. DOI: 10.1523/JNEUROSCI.4901-12.2013. View

10.

Davis M, Bjorkman P . T-cell antigen receptor genes and T-cell recognition. Nature. 1988; 334(6181):395-402. DOI: 10.1038/334395a0. View

11.

Bsat S, Halaoui A, Kobeissy F, Moussalem C, El Houshiemy M, Kawtharani S . Acute ischemic stroke biomarkers: a new era with diagnostic promise?. Acute Med Surg. 2021; 8(1):e696. PMC: 8552525. DOI: 10.1002/ams2.696. View

12.

Basic Kes V, Simundic A, Nikolac N, Topic E, Demarin V . Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem. 2008; 41(16-17):1330-4. DOI: 10.1016/j.clinbiochem.2008.08.080. View

13.

Price C, Menon D, Peters A, Ballinger J, Barber R, Balan K . Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke. 2004; 35(7):1659-64. DOI: 10.1161/01.STR.0000130592.71028.92. View

14.

Hou D, Ying T, Wang L, Chen C, Lu S, Wang Q . Immune Repertoire Diversity Correlated with Mortality in Avian Influenza A (H7N9) Virus Infected Patients. Sci Rep. 2016; 6:33843. PMC: 5037391. DOI: 10.1038/srep33843. View

15.

Zong Y, Liu Y, Wang J, Rastegar-Kashkooli Y, Fu P, Chen S . The characteristics of T-cell receptor repertoire in relation to systemic immune response of patients with ischemic stroke. J Neurochem. 2024; 169(2):e16246. DOI: 10.1111/jnc.16246. View

16.

Alves Sousa A, Johnson K, Ohayon J, Zhu J, Muraro P, Jacobson S . Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders. Sci Rep. 2019; 9(1):344. PMC: 6344574. DOI: 10.1038/s41598-018-36274-7. View

17.

Doehner W, von Haehling S, Suhr J, Ebner N, Schuster A, Nagel E . Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke. J Am Coll Cardiol. 2012; 60(4):346-54. DOI: 10.1016/j.jacc.2012.04.024. View

18.

Iadecola C, Anrather J . The immunology of stroke: from mechanisms to translation. Nat Med. 2011; 17(7):796-808. PMC: 3137275. DOI: 10.1038/nm.2399. View

19.

Fury W, Park K, Wu Z, Kim E, Woo M, Bai Y . Sustained Increases in Immune Transcripts and Immune Cell Trafficking During the Recovery of Experimental Brain Ischemia. Stroke. 2020; 51(8):2514-2525. PMC: 7815290. DOI: 10.1161/STROKEAHA.120.029440. View

20.

Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S . Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009; 15(2):192-9. DOI: 10.1038/nm.1927. View